+

ZA93811B - Methods of treating inflammatory dermatoses. - Google Patents

Methods of treating inflammatory dermatoses.

Info

Publication number
ZA93811B
ZA93811B ZA93811A ZA93811A ZA93811B ZA 93811 B ZA93811 B ZA 93811B ZA 93811 A ZA93811 A ZA 93811A ZA 93811 A ZA93811 A ZA 93811A ZA 93811 B ZA93811 B ZA 93811B
Authority
ZA
South Africa
Prior art keywords
methods
treating inflammatory
inflammatory dermatoses
dermatoses
treating
Prior art date
Application number
ZA93811A
Other languages
English (en)
Inventor
Albert M Kligman
Original Assignee
Albert M Kligman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert M Kligman filed Critical Albert M Kligman
Publication of ZA93811B publication Critical patent/ZA93811B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA93811A 1992-02-07 1993-02-05 Methods of treating inflammatory dermatoses. ZA93811B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83282892A 1992-02-07 1992-02-07

Publications (1)

Publication Number Publication Date
ZA93811B true ZA93811B (en) 1993-09-10

Family

ID=25262717

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93811A ZA93811B (en) 1992-02-07 1993-02-05 Methods of treating inflammatory dermatoses.

Country Status (12)

Country Link
US (1) US5998395A (fr)
EP (1) EP0625045A4 (fr)
JP (1) JP2927961B2 (fr)
KR (1) KR100282575B1 (fr)
AU (1) AU667519B2 (fr)
CA (1) CA2129114A1 (fr)
CZ (1) CZ188394A3 (fr)
FI (1) FI943625L (fr)
NO (1) NO942913L (fr)
NZ (1) NZ249379A (fr)
WO (1) WO1993015740A1 (fr)
ZA (1) ZA93811B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344448B1 (en) 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
WO1994006434A1 (fr) * 1992-09-11 1994-03-31 Sandra Brown Procede et composition utiles pour traiter la chute des cheveux
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
WO1996034601A1 (fr) * 1995-05-05 1996-11-07 Braiman Mark S Traitement du psoriasis a l'acide 11-cis-retinoique
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
WO1999005161A1 (fr) 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated SEQUENCES REGULATRICES DU GENE HUMAIN PPARη (RECEPTEUR GAMMA ACTIVE DE LA PROLIFERATION DES PEROXYSOMES) ET LEURS UTILISATIONS
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
US6355669B1 (en) * 1997-10-22 2002-03-12 Eisai Co., Ltd. Retinoic acid agonists as preventive and therapeutic agents for nephritis
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
FR2804323B1 (fr) 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
DE60135108D1 (de) * 2000-05-09 2008-09-11 Kaneka Corp Dermale zusammenstellungen die als wirkstoff coenzym q enthalten
WO2002022113A2 (fr) 2000-09-13 2002-03-21 Bristol-Myers Squibb Company Antagonistes vis-a-vis du recepteur d'acide retinoique, tenant lieu de promoteurs de l'angiogenese
KR20020027198A (ko) * 2000-10-02 2002-04-13 차알스 제이. 메츠 염증과 홍반의 완화방법
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
US20020146744A1 (en) * 2001-03-02 2002-10-10 Lawandy Nabil M. Combinatorial chemistry and compound identification system
ES2188426B1 (es) * 2001-12-12 2004-11-16 Rosalia Pidal Fernandez Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias.
US20030199488A1 (en) * 2002-04-23 2003-10-23 Trotta Gina M. Treatment of hyperproliferative disorders/inflammatory dermatoses
US6723755B2 (en) 2002-06-12 2004-04-20 Piotr Chomczynski Method of treating rosacea
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
WO2004037197A2 (fr) * 2002-10-24 2004-05-06 Goldstein Jay A Preparations antifongiques
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
ATE497763T1 (de) * 2003-11-21 2011-02-15 Zalicus Inc Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen
AU2005213895A1 (en) * 2004-02-19 2005-09-01 Chemaphor Inc. Topical formulations for the treatment of skin conditions
US7812057B2 (en) * 2004-08-25 2010-10-12 Molecular Research Center, Inc. Cosmetic compositions
PT1806982T (pt) 2004-09-28 2018-11-15 Avivagen Inc Composições e métodos para a promoção do aumento de peso e da conversão de alimentos
US20070009607A1 (en) * 2005-07-11 2007-01-11 George Jones Antibacterial/anti-infalmmatory composition and method
EP2214656B1 (fr) 2007-10-26 2018-12-05 Avivagen Inc. Compositions et procédés pour améliorer la réponse immunitaire
ES2327201B1 (es) 2008-04-23 2010-07-23 Ignacio Umbert Millet Composicion farmaceutica personalizada para el rejuvenecimiento de la piel que contiene acido retinoico.
CA2771204C (fr) 2009-04-30 2017-09-19 Chemaphor Inc. Procedes et compositions pour ameliorer la sante d'animaux
JP5967657B2 (ja) 2009-10-20 2016-08-10 ディスカバリー パートナーズ, エルエルシーDiscovery Partners, Llc 皮膚化粧料組成物
ES2378028B1 (es) 2012-02-22 2013-02-18 Ignacio Umbert Millet Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes
CN111372556A (zh) * 2017-09-28 2020-07-03 强生消费者公司 化妆品组合物和治疗皮肤的方法
RU2712281C1 (ru) * 2018-11-23 2020-01-28 Общество С Ограниченной Ответственностью "Хемиммьюн Терапьютикс" Применение производного глутаримида для преодоления резистентности к стероидам и терапии заболеваний, ассоциированных с аберрантным сигналингом интерферона гамма

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4126693A (en) * 1975-11-03 1978-11-21 Johnson & Johnson Retinoic acid derivatives in the treatment of acne
ZA77678B (en) * 1977-02-07 1978-09-27 S Fourie Pharmaceutical composition and use thereof
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy

Also Published As

Publication number Publication date
KR950700069A (ko) 1995-01-16
NO942913D0 (fr) 1994-08-05
WO1993015740A1 (fr) 1993-08-19
EP0625045A1 (fr) 1994-11-23
JP2927961B2 (ja) 1999-07-28
CZ188394A3 (en) 1996-02-14
FI943625A0 (fi) 1994-08-04
NO942913L (no) 1994-10-05
AU667519B2 (en) 1996-03-28
KR100282575B1 (ko) 2001-02-15
AU3585493A (en) 1993-09-03
US5998395A (en) 1999-12-07
EP0625045A4 (fr) 1995-01-18
JPH07505617A (ja) 1995-06-22
CA2129114A1 (fr) 1993-08-19
FI943625L (fi) 1994-08-04
NZ249379A (en) 1998-07-28

Similar Documents

Publication Publication Date Title
ZA93811B (en) Methods of treating inflammatory dermatoses.
GR3036347T3 (en) Compounds useful for treating allergic and inflammatory diseases.
EP0634930A4 (en) Compounds useful for treating allergic and inflammatory diseases.
EP0576178A3 (fr) Procédé pour maintenir les relations entre des éléments.
ZA945657B (en) Method to inhibit restenosis
EP0604804A3 (fr) Bande isolante et son procédé de fabrication.
IL105441A0 (en) System for treating buildings
EP0814814A4 (fr) Methodes de traitement de la thrombose
GB2265399B (en) Horizontal well treatment method
ZA939369B (en) Method of milling.
KR0166397B1 (ko) 트랜지스터 및 그 제조방법
FI935278L (fi) Avgasreningssystem foer reducering av kolvaeteutslaepp under kallstart av foerbraenningsmotorer
PL334012A1 (en) Novel method of treating the arthritis
EP0579453A3 (fr) Composition pour le traitement de maçonnerie et procédé.
EP0630383A4 (fr) Procedes de traitement des diabetes.
EP0674707A4 (fr) Composes et methodes de traitement des leucemies.
FI944236L (fi) Migreenin hoitomenetelmä
ZA933151B (en) Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds.
ZA965346B (en) Methods of treating neuropeptide Y-associated conditions.
EP0584795A3 (fr) Agent de développement électronographique et son procédé de fabrication.
EP0505086A3 (en) Method for the treatment of lamellar or plate-like materials
EP0654996A4 (fr) Procedes de traitement du psoriasis a l'aide d'azaspirannes substitues.
EP0624089A4 (en) Methods.
PL297518A1 (en) Method of obtaining 4,6-dialkoxypyrimidines
GB9321433D0 (en) Treatment of inflammatory dermatoses
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载